CHEMBIO DIAGNOSTICS, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 24 rows in 2007. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2007-06-21: Reporting owner Meller Gary; Form 4; Security Stock Option Right to Buy; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2007-06-21: Reporting owner Meller Gary; Form 4; Security Stock option Right to Buy; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2007-06-21: Reporting owner Carus Alan; Form 4; Security Stock Option Right to Buy; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2007-06-21: Reporting owner Carus Alan; Form 4; Security Stock option right to Buy; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2007-06-21 | Meller Gary Director | 4 | Stock Option Right to Buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +144,000 144,000 owned after | $0.53 | 2007-06-25 | |
| 2007-06-21 | Meller Gary Director | 4 | Stock option Right to Buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,000 36,000 owned after | $0.68 | 2007-06-25 | |
| 2007-06-21 | Carus Alan Director | 4 | Stock Option Right to Buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,000 36,000 owned after | $0.55 | 2007-06-25 | |
| 2007-06-21 | Carus Alan Director | 4 | Stock option right to Buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +144,000 144,000 owned after | $0.53 | 2007-06-25 | |
| 2007-06-21 | Davis Katherine Lyon Director | 4 | Stock Option Right to Buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +180,000 180,000 owned after | $0.53 | 2007-06-25 | |
| 2007-06-01 | Aromando Robert L Officer (Sr VP, Commercial Operations) | 4 | Stock options right to buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $0.62 | 2007-06-05 | |
| 2007-05-03 holding as of filing | Esfandiari Javan Officer (VP, Research & Development) | 3 | Stock option right to buy Derivative · Direct | Holding | $0.60 exercise price | 2007-05-03 | ||
| 2007-05-03 holding as of filing | Esfandiari Javan Officer (VP, Research & Development) | 3 | Stock option right to buy Derivative · Direct | Holding | $0.60 exercise price | 2007-05-03 | ||
| 2007-05-03 holding as of filing | Esfandiari Javan Officer (VP, Research & Development) | 3 | Stock option right to buy Derivative · Direct | Holding | $0.60 exercise price | 2007-05-03 | ||
| 2007-05-03 holding as of filing | Esfandiari Javan Officer (VP, Research & Development) | 3 | Stock option right to buy Derivative · Direct | Holding | $0.75 exercise price | 2007-05-03 | ||
| 2007-05-03 holding as of filing | Esfandiari Javan Officer (VP, Research & Development) | 3 | Stock option right to buy Derivative · Direct | Holding | $0.75 exercise price | 2007-05-03 | ||
| 2007-05-03 holding as of filing | Esfandiari Javan Officer (VP, Research & Development) | 3 | Stock option right to buy Derivative · Direct | Holding | $0.75 exercise price | 2007-05-03 | ||
| 2007-05-03 holding as of filing | Esfandiari Javan Officer (VP, Research & Development) | 3 | Stock option right to buy Derivative · Direct | Holding | $0.75 exercise price | 2007-05-03 | ||
| 2007-05-03 holding as of filing | Esfandiari Javan Officer (VP, Research & Development) | 3 | Stock option right to buy Derivative · Direct | Holding | $0.75 exercise price | 2007-05-03 | ||
| 2007-05-03 holding as of filing | Esfandiari Javan Officer (VP, Research & Development) | 3 | Stock option right to buy Derivative · Direct | Holding | $0.75 exercise price | 2007-05-03 | ||
| 2007-05-03 holding as of filing | Esfandiari Javan Officer (VP, Research & Development) | 3 | Stock option right to buy Derivative · Direct | Holding | $0.75 exercise price | 2007-05-03 | ||
| 2007-05-03 holding as of filing | Esfandiari Javan Officer (VP, Research & Development) | 3 | Stock option right to buy Derivative · Direct | Holding | $0.75 exercise price | 2007-05-03 | ||
| 2007-05-03 holding as of filing | Esfandiari Javan Officer (VP, Research & Development) | 3 | Stock option right to buy Derivative · Direct | Holding | $0.75 exercise price | 2007-05-03 | ||
| 2007-05-03 holding as of filing | Esfandiari Javan Officer (VP, Research & Development) | 3 | Stock option right to buy Derivative · Direct | Holding | $0.62 exercise price | 2007-05-03 | ||
| 2007-05-03 holding as of filing | Esfandiari Javan Officer (VP, Research & Development) | 3 | Stock option right to buy Derivative · Direct | Holding | $0.62 exercise price | 2007-05-03 | ||
| 2007-04-16 | Carus Alan Director | 4 | Stock options right to buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,000 36,000 owned after | $0.55 | 2007-04-18 | |
| 2007-03-19 | Meller Gary Director | 4 | Options right to buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,000 36,000 owned after | $0.68 | 2007-03-21 | |
| 2007-01-19 | Pelossof Avi Officer (VP Sales, Marketing & BD) | 4 | Options to purchase Common Stock Derivative · Direct | X Exercise of in-the-money or at-the-money derivative security | −25,000 0 owned after | $0.62 exercise price | 2007-01-23 | |
| 2007-01-19 | Pelossof Avi Officer (VP Sales, Marketing & BD) | 4 | Options to purchase Common Stock Derivative · Direct | X Exercise of in-the-money or at-the-money derivative security | −25,000 0 owned after | $0.62 exercise price | 2007-01-23 |